Literature DB >> 9341722

Fou rire prodromique heralding a left internal carotid artery occlusion.

C Carel1, J F Albucher, C Manelfe, B Guiraud-Chaumeil, F Chollet.   

Abstract

BACKGROUND: Four rire prodromique, described as pathological laughter preceding the onset of an apoplectic attack, is a rare phenomenon. CASE DESCRIPTION: A 61-year-old man manifested pathological laughter before a sudden right hemiplegia. MRI showed a left lenticular and caudate nucleus infarct with involvement of the external capsule and prerolandic area. MRA revealed a left internal carotid and middle cerebral artery occlusion.
CONCLUSIONS: The clinicoanatomic correlates of this phenomenon are discussed.

Entities:  

Mesh：

Year:  1997        PMID： 9341722     DOI： 10.1161/01.str.28.10.2081

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


  4 in total

1.  Smile and laughter induction and intraoperative predictors of response to deep brain stimulation for obsessive-compulsive disorder.

Authors:  Ihtsham U Haq; Kelly D Foote; Wayne G Goodman; Samuel S Wu; Atchar Sudhyadhom; Nicola Ricciuti; Mustafa S Siddiqui; Dawn Bowers; Charles E Jacobson; Herbert Ward; Michael S Okun
Journal:  Neuroimage       Date:  2010-03-10       Impact factor: 6.556

2.  Effective use of sertraline for pathological laughing after severe vasospasm due to aneurysmal subarachnoid hemorrhage: case report.

Authors:  Hayato Takeuchi; Kazuhide Iwamoto; Mao Mukai; Tomoaki Fujita; Hitoshi Tsujino; Yoshihiro Iwamoto
Journal:  Neurol Med Chir (Tokyo)       Date:  2013-11-08       Impact factor: 1.742

3.  Pathological Laughter Prodromal to a Stroke of the Head of the Left Caudate Nucleus.

Authors:  Matthew Beth Urhoy; William J House
Journal:  Case Rep Neurol       Date:  2022-01-13

Review 4.  Pathological laughter as prodromal manifestation of transient ischemic attacks--case report and brief review.

Authors:  Adriana O Dulamea; Costel Matei; Ioana Mindruta; Virgil Ionescu
Journal:  BMC Neurol       Date:  2015-10-12       Impact factor: 2.474
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.